Skip to main content
Premium Trial:

Request an Annual Quote

Febit Integrates InforSense Technology into Microarray Platform

NEW YORK (GenomeWeb News) – Febit has integrated components of the InforSense visualization platform into its new Geniom microarray system, InforSense said today.

Under the agreement, Febit has embedded the InforSense platform, workflows and visualizations, into the Geniom instruments.

The InforSense platform provides data analytics and application development capabilities, and the VisualSense provides interactive, web-based visualization tools. The Geniom is used in target sequence capture before next-generation sequencing projects and in classical transcriptomics applications.

"Our applications require a platform with the ability to handle massive amounts of data, which can then be boiled down and presented in manageable size pieces to our end-users," explained Febit's VP of Global Informatics, Anthony Caruso, in a statement. "Developing on the InforSense platform has enabled us to focus on the bioinformatics and computational algorithms, which are core to our business."

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.